Peptide-Based Supramolecular Hydrogels as Drug Delivery Agents: Recent Advances

Gels. 2022 Nov 1;8(11):706. doi: 10.3390/gels8110706.

Abstract

Supramolecular peptide hydrogels have many important applications in biomedicine, including drug delivery applications for the sustained release of therapeutic molecules. Targeted and selective drug administration is often preferential to systemic drug delivery, as it can allow reduced doses and can avoid the toxicity and side-effects caused by off-target binding. New discoveries are continually being reported in this rapidly developing field. In this review, we report the latest developments in supramolecular peptide-based hydrogels for drug delivery, focusing primarily on discoveries that have been reported in the last four years (2018-present). We address clinical points, such as peptide self-assembly and drug release, mechanical properties in drug delivery, peptide functionalization, bioadhesive properties and drug delivery enhancement strategies, drug release profiles, and different hydrogel matrices for anticancer drug loading and release.

Keywords: biomaterials; cancer therapy; controlled release; drug delivery; hydrogel; peptide; smart materials; stimuli-responsive; supramolecular.

Publication types

  • Review